16 research outputs found
Tamsulosin-induced acute liver injury: a case report
International audienceMeeting Abstract: PS-052, 20e congrès de la Société Française de Pharmacologie et de Thérapeutique, Nancy, 19-21 avril 201
Évaluation des délais de guérison des ostéochimionécroses des maxillaires après traitement chirurgical : étude rétrospective monocentrique et revue de la littérature
International audienc
3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution
International audienc
Social and professional reintegration of the French war wounded soldier. Experience of wounded person from 2004 to 2010 and hospitalized in physical medicine and rehabilitation department of the military instruction hospital (MIH) Percy
Exploration of day-surgery photoselective vaporization of the prostate (PVP) in Chinese population
Recommended from our members
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses
BRAF fusions are detected in numerous neoplasms, but their clinical management remains unresolved. We identified six melanoma lines harboring BRAF fusions representative of the clinical cases reported in the literature. Their unexpected heterogeneous responses to RAF and MEK inhibitors could be categorized upon specific features of the fusion kinases. Higher expression level correlated with resistance, and fusion partners containing a dimerization domain promoted paradoxical activation of the mitogen-activated protein kinase (MAPK) pathway and hyperproliferation in response to first- and second-generation RAF inhibitors. By contrast, next-generation αC-IN/DFG-OUT RAF inhibitors blunted paradoxical activation across all lines and had their therapeutic efficacy further increased in vitro and in vivo by combination with MEK inhibitors, opening perspectives in the clinical management of tumors harboring BRAF fusions